Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
Related Posts
Elon Musk says people against his DOGE cuts are trying to pressure Tesla to get him to stop
Shares of Tesla entered Monday down more than 34% year to date, and the stock has been cut nearly in half from its peak in […]
Nvidia announces new chips at GTC Conference. What analysts had to say
Wall Street analysts left Nvidia’s flagship GPU Technology Conference on Tuesday feeling generally optimistic on the AI darling’s future.
Microsoft CEO Nadella asked for pay reduction after security slip, but total comp still rose 63%
Following cyberattacks from China and Russia, Microsoft CEO Satya Nadella asked for his pay to be reduced.